X
Back to list

Drs. David Goodman, Leslie Citrome, Christoph Correll, Manpreet Singh and Sagar Parikh on The Hot Seat…

Introduction

Welcome back to the Psychiatry newsletter! As we move into summer, clinicians are already looking to this coming fall and its conferences for continuing education. One of the best sources of education is the upcoming dynamic, live, and in-person conference that is Psychopharmacology Update 2025 . Make your reservation now for a flight to Ohio this October to get up to speed on the most up-to-date, clinically relevant information and research in psychopharmacology.

In this issue, some faculty from both the upcoming Psychopharmacology Update and from the recent 2025 Psychiatry Update agreed to be good sports as we put them on The Hot Seat! Read on to see what they say about things both personal and professional, as you get a glimpse of these docs in a candid and telling environment!

Need CME? We’ve got you covered—Don’t Miss!

Psychopharmacology Update 2025

October 17-18, 2025; Hyatt Regency Cincinnati, Cincinnati, Ohio

  • Full 2-day meeting with interactive presentations, discussion and networking opportunities in addition to the scientific sessions.
  • Stellar agenda! Explore the latest advances in everything from judicious psychopharmacology, evidence-based combinations and management of treatment-resistant psychiatric disorders, to addiction and psychedelics—in addition to other urgent issues for practitioners.
  • Hear from internationally renowned faculty who present the most up-to-date, clinically relevant information and research.
  • Take home the kind of breakthroughs that can make a difference in your patients’ lives!
  • Register by clicking here!

Keep up to date as well on current research with this month’s Psych Resource section, featuring articles from MDEdge Psychiatry, New England Journal of Medicine, and JAMA Psychiatry—check them out below!

Thank you to Drs. David Goodman, Leslie Citrome, Christoph Correll, Manpreet Singh and Sagar Parikh for this month’s Hot Seat interview! Please contact me at colleen@cmhadvisors.com with any comments. –Colleen Hutchinson

The Hot Seat!

David Goodman

Favorite tool in your medical arsenal: My brain.

Favorite aspect of your job: Helping patients change their lives for the better.

Favorite song: Let It Be by the Beatles

Favorite advice or saying: It will be more satisfying to be a better person than a person who is right.

Favorite source of med ed: Pubmed.gov

Favorite book: Factfulness by Hans Rosling

Favorite pastime: Thinking.

Manpreet Singh

Favorite tool in your medical arsenal: Therapeutic alliance

Favorite aspect of your job: Helping people develop insight and build courage to change.

Favorite song: The First Time Ever I Saw Your Face (RIP Roberta Flack)

Favorite advice or saying: The purpose of negative emotions is not to cause misery. It's to prevent mistakes...Where we hurt is a clue to what we value.

Favorite source of med ed: NEI and Medscape, of course!

Favorite book: The Nurture Effect by Anthony Biglan

Favorite pastime: Hiking

Leslie Citrome

Favorite tool in your medical arsenal: The metrics of evidence-based medicine: NNT, NNH, and LHH

Favorite aspect of your job: Having people tell me years later that I changed the way they look at data

Favorite song: Smoke on the Water

Favorite advice or saying: The proof of the pudding is in the tasting

Favorite source of med ed: Journal articles

Favorite book: Tough call - I read quite a bit of science fiction and history

Favorite pastime: Sedentary hobbies (I have a lot of hobbies)

Christoph Correll

Favorite tool in your medical arsenal: Personalized psychiatry

Favorite aspect of your job: Lifelong learning

Favorite song: Sposa son disprezzata by Antonio Vivaldi, interpreted by Cecilia Bartoli

Favorite advice or saying: "The perfect is the enemy of the good"

Favorite source of med ed: Medscape

Favorite book: Gantenbein by Max Frisch

Favorite pastime: Hill walking

Drs. Singh and Parikh, at the recent 2025 Psychiatry Update you both co-presented Advances in Depression Care: Enhancing QOL with Fast-Acting Therapeutics. What are some of the latest or most effective therapeutics for patients?

Dr. Singh: Some novel new mechanisms and rapid-acting antidepressants like esketamine are showing promise, as well as neuromodulatory approaches to treating depression. Bright horizons for those suffering with depression!

Dr. Parikh: Ketamine and zuranolone.

You also co-presented Difficult-to-Treat Mental Health Conditions: Barriers and Interventions. Have any approaches significantly changed over time as more is learned about each condition and its barriers?

Dr. Singh: Thankfully, there's less stigma but there remain significant barriers to treating difficult-to-treat conditions so long as there is no support for developing new treatments, and our current political climate seems keen to cancel mental health research without considering the potential harms done to patients when they cannot access treatments. Once they do get access, current treatments only work about 1/3 of the time, which doesn't inspire a lot of confidence. We have to do better than that.

You participated in the Expert Debate on pharmacogenomic testing. What was the most highly debated aspect of this topic?

Dr. Parikh: The balance between pragmatism/ clinical wisdom and research purity.

Psychiatry Resource Section

JAMA Psychiatry Brief Report— Cannabis Withdrawal and Psychiatric Intensive Care

Medscape Medical News Commentary: How One Dose of Psilocybin Treats Depression

JAMA Psychiatry Original Investigation— Differential Associations of Dopamine and Serotonin With Reward and Punishment Processes in Humans: A Systematic Review and Meta-Analysis

Medscape Medical News Article: Loneliness Among US Adults: A Growing Concern?

New England Journal of Medicine Original Article: Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

Medscape Medical News MedBrief: Study Underscores Need for Eye Exam in Psych Disorders

Medscape Medical News MedBrief: The Head and the Heart: Managing a ‘Silent Epidemic’

APA Learning Center Free Course: Opioid Use Disorder and Harm Reduction in the Era of Poly-Substance Use—CME: 1.0, COP: 1.0

New England Journal of Medicine Perspective: Unrest

Disclaimer: Entering your email address automatically subscribes you to future email communications from MedscapeLIVE events.